HomeEndologix

Endologix

Endologix, Inc. Announces Enrollment of First Patients in ELEVATE IDE Clinical Study

First Patients in ELEVATE IDE Clinical Study Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic disorders, announced today that the first patients were treated in the Expanding Patient Applicability with Polymer Sealing Ovation Alto...